MedCap AB (publ) (FRA:61MA)

Market Cap	701.29M -6.9%
Revenue (ttm)	180.16M +11.2%
Net Income	17.81M -13.6%
EPS	1.19 -14.2%
Shares Out	n/a
PE Ratio	39.38
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	3
Open	48.50
Previous Close	47.55
Day's Range	48.50 - 48.50
52-Week Range	29.40 - 59.60
Beta	n/a
RSI	41.27
Earnings Date	Feb 6, 2026

About MedCap AB

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, pharmaceuticals, med tech and assistive tech companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Nordic region and Northern Europe. It typically invests between SEK25 millio...

• Industry: Investors, not elsewhere classified
• Founded: 2001
• Employees: 592
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 61MA

Financial Performance

In 2024, MedCap AB's revenue was 1.81 billion, an increase of 13.74% compared to the previous year's 1.59 billion. Earnings were 207.40 million, an increase of 20.44%.

Financial numbers in SEK